French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform. The company provides gene and cell therapy companies with predictive software simulations. It uses machine learning and deep learning to process multiple scientific hypotheses at once. The platform is designed to aid the discovery and development of genomic therapies.